DOCSLIB.ORG

Interleukin-6 Family Cytokines

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Interleukin-6 Family Cytokines Downloaded from http://cshperspectives.cshlp.org/ on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press Interleukin-6 Family Cytokines Stefan Rose-John Institute of Biochemistry, Kiel University, Olshausenstrasse 40, Kiel, Germany Correspondence: [email protected] The interleukin (IL)-6 family cytokines is a group of cytokines consisting of IL-6, IL-11, ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), oncostatin M (OSM), cardiotro- phin 1 (CT-1), cardiotrophin-like cytokine (CLC), and IL-27. They are grouped into one family because the receptorcomplex of each cytokine contains two (IL-6 and IL-11) or one molecule (all others cytokines) of the signaling receptor subunit gp130. IL-6 family cytokines have overlapping but also distinct biologic activities and are involved among others in the regula- tion of the hepatic acute phase reaction, in B-cell stimulation, in the regulation of the balance betweenregulatoryandeffectorTcells,inmetabolicregulation,andinmanyneuralfunctions. Blockade of IL-6 family cytokines has been shown to be beneficial in autoimmune diseases, but bacterial infections and metabolic side effects have been observed. Recent advances in cytokine blockade might help to minimize such side effects during therapeutic blockade. ytokines are small (15–20 kDa) and short- bopoietin, leukemia inhibitory factor (LIF), Clived proteins important in autocrine, para- and oncostatin M (OSM). Moreover, all inter- crine, and endocrine signaling. Cytokines coor- ferons and many colony-stimulating factors dinate the development and the activity of the (CSFs) belong to this class of cytokines, which immune system (Gandhi et al. 2016). Many cy- altogether contains far more than 60 members tokines belong to the four a-helical class of me- (Spangler et al. 2015). diators, which share a common up-up–down- Interleukin (IL)-6 family cytokines are de- down topology of the four helices. Furthermore, finedascytokinesthatusethecommonsignaling cytokines are grouped into families according to receptor subunit glycoprotein 130 kDa (gp130). the structure and the specificity and composi- Presently, eight cytokines fulfill this criterion tion of their receptorcomplexes. Cytokines bind although, as will be explained below, the group tomultimeric receptorcomplexesinwhichoften of IL-6 family cytokines is still expanding and one subunit is also found in the receptor com- the definition of gp130-containing complexes plexes for other cytokines (Spangler et al. 2015). needs to be revised (Rose-John et al. 2015). This is a reasonable classification because com- IL-6 family cytokines have been implicated in mon receptor subunits imply similarity or even many functions, including B-cell stimulation and identity in intracellular signal transduction. induction of the hepatic acute phase proteins. The class of four-helical cytokines consists Moreover, metabolic functions and neurotrophic of more than 35 interleukins and many media- functions have been ascribed to this group of tors with trivial names such as growth hor- cytokines. Lately, an IL-6 receptor (IL-6R)-neu- mone, prolactin, leptin, erythropoietin, throm- tralizing monoclonal antibody (tocilizumab) has Editors: Warren J. Leonard, and Robert D. Schreiber Additional Perspectives on Cytokines available at www.cshperspectives.org Copyright # 2017 Cold Spring Harbor Laboratory Press; all rights reserved Advanced Online Article. Cite this article as Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a028415 1 Downloaded from http://cshperspectives.cshlp.org/ on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press S. Rose-John been approved in more than 100 countries for cDNA coding for the human IL-6R (Yamasaki the treatment of autoimmune diseases (Tanaka et al. 1988). The receptor belonged to the im- et al. 2014), and blockade of IL-6 activity was munoglobulin (Ig) superfamily but the cyto- observed to be at least as efficient as the block- plasmic portion lacked a domain with discern- ade of tumor necrosis factor a in patients with ible enzymatic activity, thus failing to provide rheumatoid arthritis (Gabay et al. 2013). any clue regarding the mechanism of signal This review covers the identification and transduction induced by IL-6. Figure 1 shows complementary DNA (cDNA) cloning of IL-6 how IL-6 and IL-6R were seen during these early family cytokines, the identification of their cog- days of the cytokine field when there was no nate receptors, and the recognition that these information on the structure of these molecules. cytokines form a large family of mediators, Because cytokines show very little homology which are involved in the coordination of the at the protein level, it was not clear at the time immune system but also in many other physio- that cytokines share common features and actu- logic functions as well. ally belong to a common protein family. At this time, a seminal article was published by Bazan (1990), who hypothesized that cytokines such as CLONING OF IL-6, IL-6R, AND gp130: growth hormone, prolactin, IL-6, G-CSF, and THE IL-6R COMPLEX erythropoietin belong to the protein family When the cDNA coding for B-cell stimulatory of four-helical cytokines. Bazan stated that factor 2 (BSF-2) was cloned in 1986 by the Ki- lymphokines, interleukins, CSFs, growth hor- shimoto group, the comparison of its protein mones, and interferons, which he collectively sequence with the protein sequences of IL-1, IL- designated as cytokines, display no (or at best 2, IL-4, interferon g (IFN-g), granulocyte mac- fragmentary) similarities in amino acid se- rophage colony-stimulating factor (GM-CSF), quence. All these proteins, however, were pre- and granulocyte colony-stimulating factor (G- dicted or had been shown to be rich in a-helices. CSF) yielded only some faint similarities with Based on the then already-published X-ray G-CSF (Hirano et al. 1986). It became, however, structure of G-CSF (Abdel-Meguid et al. 1987) immediately clear from the cDNA sequence that and the high predicted helical content of growth BSF-2 was identical to several other proteins hormone, prolactin, IL-6, G-CSF, and erythro- with completely different biologic activities (Ta- poietin, Bazan suggested a four-helical tertiary ble 1), indicating that the activity of the newly fold for cytokines, an idea that he also backed by cloned BSF-2 was not restricted to the immune the conserved gene exon/intron boundaries system. In December 1988, a group of 19 leading flanking the helices and by conserved disulfide scientists in the field, including Dr. Kishimoto, bridge patterns (Bazan 1990). Based on his agreed to refer to the protein as IL-6 (The New model, Bazan even detected that the protein to- York Academy of Sciences Conference 1988). pology in the then-published X-ray structure of No structural or functional information IL-2 was incorrect and needed correction (Ba- on IL-6 or the IL-6R complex was available zan 1992). Now we know that all cytokines of the until, in 1988, the Kishimoto group cloned the IL-6 family, but also essentially all other cyto- kines, share the four-helices with an up-up– Table 1. Synonyms of interleukin-6 as evidenced on down-down topology (Fig. 1). It was recognized complementary DNA (cDNA) cloning of B-cell stim- that, instead of showing clear sequence homol- ulatory factor 2 (BSF-2) ogy, cytokines are characterized by a high struc- B-cell stimulatory factor-2 (Hirano et al. 1986) tural homology (Spangler et al. 2015). Such Hepatocyte-stimulating factor (Gauldie et al. 1987) structural homology extends to cytokine recep- Hybridoma-plasmacytoma growth factor tors, which all belong to the Ig superfamily and (Brakenhoff et al. 1987) which contain a cytokine-binding module con- Interferon b2 (Zilberstein et al. 1986) sisting of tandem fibronectin III domains where 26 kDa protein (Haegeman et al. 1986) the amino-terminal domain contains a set of 2 Advanced Online Article. Cite this article as Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a028415 Downloaded from http://cshperspectives.cshlp.org/ on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press IL-6 Family Cytokines ABS NH2 S Ig domain ≈ Site 1 S 90 aa NH2 S COOH S ≈ 250 aa IL-6R S Transmembrane ≈ IL-6 domain 28 aa Cytoplasmic ≈ COOH domain 82 aa CDA-B C-D C-D loop Helix loop Helix Helix loop Helix B-C loop GRH NH2 A B C D COOH PRL NH2 A B C D COOH B A-B loop IL-6 NH2 A B C D COOH D A C G-CSF NH A B C D COOH 2 IL-6 EPO NH A B C D COOH 2 NH COOH 2 Figure 1. Recognition of interleukin-6 (IL-6) as a four-helical cytokine with up-up–down-down topology. (A) IL-6 was functionally characterized by sets of monoclonal antibodies and it was stated that the NH2 terminus and the COOH terminus must be in close proximity in the biologic active IL-6 protein (Brakenhoff et al. 1990). Hypothesized disulfide bridges are indicated in red. (B) When the complementary DNA (cDNA) coding for the IL-6 receptor (IL-6R) was cloned, no details about structure or function were available and only a schematic model of the IL-6R as a member of the immunoglobulin (Ig) superfamily could be envisioned (Hirano et al. 1989). A single hypothesized disulfide bridge is shown in blue. Postulated N-glycosylation sites are shown in green. (C) It was recognized by Bazan (1990) that, although growth hormone (GRH), prolactin (PRL), IL-6, granulocyte colony-stimulating factor (G-CSF), and erythropoietin (EPO) (Bazan 1990) display no (or at best fragmentary) similarities in amino acid sequence, they share exon–intron boundaries at predicted secondary structure elements (red arrowheads) and predicted disulfide bridges. Based on the known three-dimensional structure of G-CSF (Abdel-Meguid et al. 1987), Bazan postulated that GRH, PRL, IL-6, G-CSF,and EPO formed a structurally related family of cytokines.
Load more

Recommended publications
  • Cytokine Nomenclature
    RayBiotech, Inc. The protein array pioneer company Cytokine Nomenclature Cytokine Name Official Full Name Genbank Related Names Symbol 4-1BB TNFRSF Tumor necrosis factor NP_001552 CD137, ILA, 4-1BB ligand receptor 9 receptor superfamily .2. member 9 6Ckine CCL21 6-Cysteine Chemokine NM_002989 Small-inducible cytokine A21, Beta chemokine exodus-2, Secondary lymphoid-tissue chemokine, SLC, SCYA21 ACE ACE Angiotensin-converting NP_000780 CD143, DCP, DCP1 enzyme .1. NP_690043 .1. ACE-2 ACE2 Angiotensin-converting NP_068576 ACE-related carboxypeptidase, enzyme 2 .1 Angiotensin-converting enzyme homolog ACTH ACTH Adrenocorticotropic NP_000930 POMC, Pro-opiomelanocortin, hormone .1. Corticotropin-lipotropin, NPP, NP_001030 Melanotropin gamma, Gamma- 333.1 MSH, Potential peptide, Corticotropin, Melanotropin alpha, Alpha-MSH, Corticotropin-like intermediary peptide, CLIP, Lipotropin beta, Beta-LPH, Lipotropin gamma, Gamma-LPH, Melanotropin beta, Beta-MSH, Beta-endorphin, Met-enkephalin ACTHR ACTHR Adrenocorticotropic NP_000520 Melanocortin receptor 2, MC2-R hormone receptor .1 Activin A INHBA Activin A NM_002192 Activin beta-A chain, Erythroid differentiation protein, EDF, INHBA Activin B INHBB Activin B NM_002193 Inhibin beta B chain, Activin beta-B chain Activin C INHBC Activin C NM005538 Inhibin, beta C Activin RIA ACVR1 Activin receptor type-1 NM_001105 Activin receptor type I, ACTR-I, Serine/threonine-protein kinase receptor R1, SKR1, Activin receptor-like kinase 2, ALK-2, TGF-B superfamily receptor type I, TSR-I, ACVRLK2 Activin RIB ACVR1B
    [Show full text]
  • Genetic Determinants of Circulating Interleukin-1 Receptor Antagonist Levels and Their Association with Glycemic Traits
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Trepo - Institutional Repository of Tampere University GENETIC DETERMINANTS OF CIRCULATING INTERLEUKIN-1 RECEPTOR ANTAGONIST LEVELS AND THEIR ASSOCIATION WITH GLYCEMIC TRAITS Marja-Liisa Nuotio Syventävien opintojen kirjallinen työ Tampereen yliopisto Lääketieteen yksikkö Tammikuu 2015 Tampereen yliopisto Lääketieteen yksikkö NUOTIO MARJA-LIISA: GENETIC DETERMINANTS OF CIRCULATING INTERLEUKIN-1 RECEPTOR ANTAGONIST LEVELS AND THEIR ASSOCIATION WITH GLYCEMIC TRAITS Kirjallinen työ, 57 s. Ohjaaja: professori Mika Kähönen Tammikuu 2015 Avainsanat: sytokiinit, insuliiniresistenssi, tyypin 2 diabetes, tulehdus, glukoosimetabolia, genominlaajuinen assosiaatioanalyysi (GWAS) Tulehdusta välittäviin sytokiineihin kuuluvan interleukiini 1β (IL-1β):n kohonneen systeemisen pitoisuuden on arveltu edesauttavan insuliiniresistenssin kehittymistä ja johtavan haiman β-solujen toimintahäiriöihin. IL-1β:n sisäsyntyisellä vastavaikuttajalla, interleukiini 1 reseptoriantagonistilla (IL-1RA), on puolestaan esitetty olevan suojaava rooli mainittujen fenotyyppien kehittymisessä päinvastaisten vaikutustensa ansiosta. IL-1RA:n suojaavan roolin havainnollistamiseksi työssä Genetic determinants of circulating interleukin-1 receptor antagonist levels and their association with glycemic traits tunnistettiin veren IL-1RA- pitoisuuteen assosioituvia geneettisiä variantteja, minkä jälkeen selvitettiin näiden yhteyttä glukoosi- ja insuliinimetaboliaan liittyvien muuttujien-, sekä
    [Show full text]
  • (CS-ⅣA-Be), a Novel IL-6R Antagonist, Inhibits IL-6/STAT3
    Author Manuscript Published OnlineFirst on February 29, 2016; DOI: 10.1158/1535-7163.MCT-15-0551 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Chikusetsusaponin Ⅳa butyl ester (CS-Ⅳa-Be), a novel IL-6R antagonist, inhibits IL-6/STAT3 signaling pathway and induces cancer cell apoptosis Jie Yang 1, 2, Shihui Qian 2, Xueting Cai 1, 2, Wuguang Lu 1, 2, Chunping Hu 1, 2, * Xiaoyan Sun1, 2, Yang Yang1, 2, Qiang Yu 3, S. Paul Gao 4, Peng Cao 1, 2 1. Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China 2. Laboratory of Cellular and Molecular Biology, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing 210028, China 3. Shanghai Institute of Materia Medical, Chinese Academy of Sciences, Shanghai, 201203, China 4. Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY10065, USA Running title: CS-Ⅳa-Be, a novel IL-6R antagonist, inhibits IL-6/STAT3 Keywords: Chikusetsusaponin Ⅳ a butyl ester (CS- Ⅳ a-Be), STAT3, IL-6R, antagonist, cancer Grant support: P. Cao received Jiangsu Province Funds for Distinguished Young Scientists (BK20140049) grant, J. Yang received National Natural Science Foundation of China (No. 81403151) grant, and X.Y. Sun received National Natural Science Foundation of China (No. 81202576) grant. Corresponding author: Peng Cao Institute: Laboratory of Cellular and Molecular Biology, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing 210028, Jiangsu, China Mailing address: 100#, Shizi Street, Hongshan Road, Nanjing, Jiangsu, China Tel: +86-25-85608666 Fax: +86-25-85608666 Email address: [email protected] The first co-authors: Jie Yang and Shihui Qian The authors disclose no potential conflicts of interest.
    [Show full text]
  • IL-21R, Human, Recombinant (Sf9) Recombinant Human Interleukin 21 Receptor (Sf9 Cell-Derived)
    IL-21R, human, recombinant (Sf9) Recombinant Human Interleukin 21 Receptor (Sf9 cell-derived) Instruction Manual Catalog Number C-62924 Synonyms Interleukin 21 Receptor, Novel Interleukin Receptor, IL-21 Receptor, NILR, Interleukin-21 Receptor, CD360 Antigen, IL-21R, CD360 Description Interleukin-21 receptor, also known as IL-21R is a member of the type I cytokine receptors family. IL-21R forms a heterodimeric receptor complex with the common gamma-chain, a receptor subunit which is also shared by the receptors for Interleukin 2, 4, 7, 9, and 15. Furthermore, IL-21 receptor transduces the growth promoting signal of IL-21, and is significant for the proliferation as well as differentiation of T cells, B cells, and natural killer (NK) cells. The ligand binding of IL-21 receptor leads to the activation of numerous downstream signaling molecules, including JAK1, JAK3, STAT1, as well as STAT3. IL21R produced in Sf9 cells is a single, glycosylated polypeptide chain (20-232 a.a.) fused to an 8 aa His-tag at the C-terminus. It contains a total of 221 amino acids and has a molecular mass of 25.6 kDa. IL-21R shows multiple bands between 28-40 kDa on SDS-PAGE under reducing conditions and has been purified using proprietary chromatographic techniques. Quantity 10 µg Molecular Mass 25.6 kDa Source Sf9 cells Biological-Activity NA Specific Activity NA Formulation Sterile-filtered colorless protein solution (1 mg/ml) containing phosphate buffered saline (pH 7.4) and 10% glycerol. Reconstitution Please Note: Always centrifuge product briefly before opening vial. The dissolved protein can be diluted into other aqueous buffers and stored at -20°C for future use.
    [Show full text]
  • Structure-Based Tuning of Interleukin Receptor Complexes to Promote Anti- Tumor Immunity
    Science Highlight – July 2021 Structure-based Tuning of Interleukin Receptor Complexes to Promote Anti- tumor Immunity Cells of the immune system communicate messages between them via small secreted complexes called cytokines. Cytokines are recognized by other cells through membrane receptors. These cell signaling pathways convey information about pathogens, cancers, or other problems that concern the immune system. Two of these cytokines, interleukin 12 (IL- 12) and Interleukin 23 (IL-23) are made by antigen-presenting cells and help to activate lymphocytes, including both T and NK cells. IL-12 and IL-23 have similar structures, which include a four-helix bundle α-subunit and a β- subunit called p40. Despite intense basic research and clinical interest in IL-12 and IL-23, a structural basis for receptor assembly has remained elusive. In work led by the Garcia group at Stanford University, researchers determined the crystal structure of the complete IL-23 receptor complex using x-ray crystallography data collected on SSRL beam line 12-2. Figure 1. Structural mechanism of IL-12 and IL-23 receptor assembly enables graded control of downstream signaling. (A) The 3.4 Å resolution crystal structure of the IL-23 receptor complex. P40 (orange) bridges IL-23 and IL-12. (B-C) CryoEM maps of the IL-23 (8 Å) and IL-12 (10 Å) receptor complexes, respectively. (D-E) Graded control of IL-12 and IL-23 signaling. STAT phosphorylation was analyzed by flow cytometry. The structure revealed that IL-23 uses the four-helix bundle and p40 subunits to engage its’ receptors in a modular fashion (Fig.
    [Show full text]
  • Inflammation-Induced IL-6 Functions As a Natural Brake On
    BASIC RESEARCH www.jasn.org Inflammation-Induced IL-6 Functions as a Natural Brake on Macrophages and Limits GN Michael Luig,* Malte A. Kluger,* Boeren Goerke,* Matthias Meyer,* Anna Nosko,* † ‡ † Isabell Yan, Jürgen Scheller, Hans-Willi Mittrücker, Stefan Rose-John,§ Rolf A.K. Stahl,* Ulf Panzer,* and Oliver M. Steinmetz* *Medical Clinic III and †Immunology Institute, Hamburg University Medical Center, Hamburg, Germany; ‡Institute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; and §Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany ABSTRACT IL-6 can mediate proinflammatory effects, and IL-6 receptor (IL-6R) blockade as a treatment for in- flammatory diseases has entered clinical practice. However, opposing effects of IL-6 have been observed in models of GN. Although IL-6 is proinflammatory in murine lupus nephritis, protective effects have been observed for IL-6 in the nephrotoxic nephritis (NTN) model of acute crescentic GN. In light of the potential dangers of IL-6–directed treatment, we studied the mechanisms underlying the contradictory findings in GN. IL-6 can signal through the membrane-bound IL-6R, which is expressed only on hepatocytes and certain leukocytes (classic), or through the soluble IL-6R, which binds the ubiquitously expressed gp130 (alternative). Preemptive treatment of mice with anti-IL-6R or anti-IL-6 worsened NTN, whereas selective blockade of alternative IL-6 signaling by the fusion protein sgp130Fc did not. FACS analysis of mouse spleen cells revealed proinflammatory macrophages express the highest levels of IL-6Ra,andin vitro treatment with IL-6 blocked macrophage proliferation. Furthermore, proinflammatory macrophages were 2 2 expanded during inflammation in IL-6 / mice.
    [Show full text]
  • Anti-Human IL-21 Purified Catalog Number: 14-6465 Also Known As: Interleukin-21, IL21 RUO: for Research Use Only
    Page 1 of 2 Anti-Human IL-21 Purified Catalog Number: 14-6465 Also known as: Interleukin-21, IL21 RUO: For Research Use Only. Not for use in diagnostic procedures. Immunoblot analysis of reduced HL60 cell lysates using Anti-Human IL-21 Purified (1µg/ml) and detected using Anti-Rabbit IgG-HRP. Product Information Contents: Anti-Human IL-21 Purified Formulation: aqueous buffer, 0.09% sodium Catalog Number: 14-6465 azide, may contain carrier protein/stabilizer Clone: Polyclonal Temperature Limitation: Store at 2-8°C. Host/Isotype: Rabbit IgG Batch Code: Refer to vial Use By: Refer to vial Caution, contains Azide Description The rabbit polyclonal antibody reacts with human IL-21; the antibody was raised against a synthetic peptide (tcpscdsyekkppke) corresponding to amino acids 121 to 135 of human IL-21 precursor (1). A novel cytokine was recently identified in human and mouse and designated IL-21 (1), which has significant homology to IL-2, IL-4, and IL- 15. The receptor for IL-21 (IL-21R, also termed NILR for novel Interleukin receptor) is a new member of the class I cytokine receptor family (1,2). IL-21R forms a complex with the common cytokine receptor g chain, gc, and mediates IL-21 signaling (3,4). IL-21 and its receptor activate JAK-STAT signaling pathway. IL-21 is expressed in activated T cells, and HL-60 and THP-1 cell lines. IL-21 plays a role in the proliferation and maturation of NK, B and T cell populations. Applications Reported This polyclonal antibody has been reported for use in immunoblotting (WB).
    [Show full text]
  • Comprehensive Association Study of Genetic Variants in the IL-1 Gene Family in Systemic Juvenile Idiopathic Arthritis
    Genes and Immunity (2008) 9, 349–357 & 2008 Nature Publishing Group All rights reserved 1466-4879/08 $30.00 www.nature.com/gene ORIGINAL ARTICLE Comprehensive association study of genetic variants in the IL-1 gene family in systemic juvenile idiopathic arthritis CJW Stock1, EM Ogilvie1, JM Samuel1, M Fife1, CM Lewis2 and P Woo1 1Centre for Paediatric and Adolescent Rheumatology, Windeyer Institute for Medical Sciences, University College London, London, UK and 2Guy’s, Kings and St Thomas’ School of Medicine, London, UK Patients with systemic juvenile idiopathic arthritis (sJIA) have a characteristic daily spiking fever and elevated levels of inflammatory cytokines. Members of the interleukin-1 (IL-1) gene family have been implicated in various inflammatory and autoimmune diseases, and treatment with the IL-1 receptor antagonist, Anakinra, shows remarkable improvement in some patients. This work describes the most comprehensive investigation to date of the involvement of the IL-1 gene family in sJIA. A two-stage case–control association study was performed to investigate the two clusters of IL-1 family genes using a tagging single nucleotide polymorphism (SNP) approach. Genotyping data of 130 sJIA patients and 151 controls from stage 1 highlighted eight SNPs in the IL1 ligand cluster region and two SNPs in the IL1 receptor cluster region as showing a significant frequency difference between the populations. These 10 SNPs were typed in an additional 105 sJIA patients and 184 controls in stage 2. Meta-analysis of the genotypes from both stages showed that three IL1 ligand cluster SNPs (rs6712572, rs2071374 and rs1688075) and one IL1 receptor cluster SNP (rs12712122) show evidence of significant association with sJIA.
    [Show full text]
  • Human IL-18R1 Accusignal ELISA Kit - KOA0744
    Human IL-18R1 AccuSignal ELISA Kit - KOA0744 Code: KOA0744 Size: 1 Kit Product Description: Human IL-18R1 AccuSignal ELISA Kit - KOA0744 PhysicalState: Label Unconjugated Gene Name IL18R1 Species Reactivity Human Storage Condition Store vials at 4°C prior to opening. Centrifuge product if not completely clear after standing at room temperature. This product is stable for 6 months at 4°C as an undiluted liquid. Dilute only prior to immediate use. For extended storage freeze at -20°C or below for 12 months. Avoid cycles of freezing and thawing. Synonyms CD218 antigen-like family member A, CD218a, CDw218a, CDw218a antigen, IL 1Rrp, IL-18R-1, IL-18R1, IL- 1Rrp, IL1 receptor related protein, IL1 receptor-related protein, IL18R_HUMAN, IL18R1, IL18RA, Il18ralpha, IL1R-rp, IL1RRP, Interleukin 18 receptor 1, Interleukin 18 receptor alpha chain, Interleukin-18 receptor 1 Application Note Useful in Sandwich ELISA for Quantitative Detection of Antigen. Aliquot 0.1ml per well of the 2000pg/ml, 1000pg/ml, 500pg/ml, 250pg/ml, 125pg/ml, 62.5pg/ml, 31.2pg/ml human IL-18R1 standard solutions into the precoated 96-well plate. Add 0.1ml of the sample diluent buffer into the control well (Zero well). Add 0.1ml of each properly diluted sample of human cell culture supernates, serum or plasma(heparin, EDTA) to each empty well. It is recommended that each human IL-18R1 standard solution and each sample be measured in duplicate. Background The interleukin-18 receptor 1(IL-18R1), also known as CDw218a(cluster of differentiation w218a) or IL18RA, is an interleukin receptor of the immunoglobulin superfamily.
    [Show full text]
  • The Interleukin-18 Receptor Is Differentially Expressed in Whole
    1 The interleukin-18 receptor is differentially expressed in the blood during sepsis. 2 3 Shahan Mamoor, MS1 4 [email protected] East Islip, NY, USA 5 6 We probed published and public microarray datasets1,2 to discover the most significant gene expression changes in the blood of patients with sepsis. We found significant induction 7 expression of IL18RAP and IL18R1, genes encoding subunits of the interleukin-18 receptor, in 8 whole blood from patients with sepsis. 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Keywords: sepsis, septic shock, interleukin-18, IL18R1, IL18RAP, systems biology of septic 26 shock. 27 28 PAGE 1 OF 13 1 Septic shock is a leading cause of mortality in the United States and worldwide3. We 2 used published and public microarray datasets1,2 to identify differentially expressed genes in the 3 4 blood of patients with sepsis. We identified IL18R1 and IL18RAP as among the genes most 5 differentially expressed in blood in the septic state. 6 7 Methods 8 9 We utilized microarray datasets GSE1001591 and GSE264402 for this differential gene 10 11 expression analysis of blood cells during sepsis. GSE100509 was generated with whole blood 12 using Illumina HumanWG-6 v3.0 expression beadchip technology with n=12 whole blood from 13 control subjects and n=33 whole blood from sepsis patients. GSE26440 was generated using 14 15 Affymetrix Human Genome U133 Plus 2.0 Array technology with n=32 control subjects and 16 n=98 sepsis patients. The Benjamini and Hochberg method of p-value adjustment was used for 17 ranking of differential expression but raw p-values were used for assessment of statistical 18 19 significance of global differential expression.
    [Show full text]
  • Kcnorman 1.Pdf
    A Computational Systems Approach to Elucidate New Mechanisms Involved in Progressive Lung Disease by Katy Norman A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Biomedical Engineering) in the University of Michigan 2020 Doctoral Committee: Assistant Professor Kelly Arnold, Chair Professor Jeffrey Curtis Professor Jennifer Linderman Professor Bethany Moore Professor David Sept Katy C. Norman [email protected] ORCID iD: 0000-0001-8841-0212 © Katy C. Norman 2020 Acknowledgements When I look back on myself in 2015 as I just entered the PhD program, I have to give a little laugh about all the surprises and changes that have happened along the way. I have grown more than I could ever have imagined – I have become so much more comfortable and confident in my communication skills, in my scientific skills, and in myself. These changes and this growth could not have happened without my huge support network, and I am honored to have the chance to thank everyone for what they have given me and for what they have helped me achieve. I would first like to thank my adviser, Kelly Arnold, for giving me a chance to try out computational systems biology research when I had absolutely no background in the field coming in. I appreciate how you were easily able to create a space where I felt comfortable to learn, to ask questions, and to make mistakes as I worked towards gaining expertise in this field. Thank you for always being there for me with extra support when my nerves were getting the best of me before big presentations or before a big deadline, and for supporting my involvement in activities outside of the lab as well.
    [Show full text]
  • GP130 Cytokines in Breast Cancer and Bone
    cancers Review GP130 Cytokines in Breast Cancer and Bone Tolu Omokehinde 1,2 and Rachelle W. Johnson 1,2,3,* 1 Program in Cancer Biology, Vanderbilt University, Nashville, TN 37232, USA; [email protected] 2 Vanderbilt Center for Bone Biology, Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA 3 Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA * Correspondence: [email protected]; Tel.: +1-615-875-8965 Received: 14 December 2019; Accepted: 29 January 2020; Published: 31 January 2020 Abstract: Breast cancer cells have a high predilection for skeletal homing, where they may either induce osteolytic bone destruction or enter a latency period in which they remain quiescent. Breast cancer cells produce and encounter autocrine and paracrine cytokine signals in the bone microenvironment, which can influence their behavior in multiple ways. For example, these signals can promote the survival and dormancy of bone-disseminated cancer cells or stimulate proliferation. The interleukin-6 (IL-6) cytokine family, defined by its use of the glycoprotein 130 (gp130) co-receptor, includes interleukin-11 (IL-11), leukemia inhibitory factor (LIF), oncostatin M (OSM), ciliary neurotrophic factor (CNTF), and cardiotrophin-1 (CT-1), among others. These cytokines are known to have overlapping pleiotropic functions in different cell types and are important for cross-talk between bone-resident cells. IL-6 cytokines have also been implicated in the progression and metastasis of breast, prostate, lung, and cervical cancer, highlighting the importance of these cytokines in the tumor–bone microenvironment. This review will describe the role of these cytokines in skeletal remodeling and cancer progression both within and outside of the bone microenvironment.
    [Show full text]